Susan Hasty, Publisher
Table of Contents . . . September 16th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in FDA Law Weekly | Other Publications
Abbott Laboratories - FDA clears test that aids in heart attack detection
Advanced Bionics - HiResolution bionic ear system proven safe for MRI
Arthritis Drug - Merck defends arthritis drug's safety after critical FDA study
Aventis - FDA approves Taxotere for the treatment of women with early-stage breast cancer
Avian Influenza - World Health Organization says more funding needed to investigate bird flu
Best Practices, LLC - Research firm finds employee development and staffing tactics increase compliance
Best Practices, LLC - Study shows few pharmaceutical companies have moved to assure brand security
BioPort Corporation - IND accepted by FDA for anthrax immunity-stimulating molecule
Boston Scientific Corp. - FDA approves extension of expiration date for TAXUS Express2 stent system
Business Update - Specialty hospitals grow, but financial performance mixed
Cardiac Science, Inc. - FDA grants clearance to market Powerheart AED G3 PRO defibrillator
Chiron Corp. - Company produces further pandemic-like influenza vaccines for NIH studies
Columbia University - FDA updates its review of antidepressant drugs in children
Concentric Medical - FDA clears device for removing blood clots in stroke patients
Dalhousie University - West Nile virus screening of donated organs counterproductive
Agennix, Inc. - Anticancer activity of natural immunomodulatory protein reported
Amgen, Inc. - Acquisition of Tularik completed
Bariatric Surgery - Bariatric Surgery Centers of Excellence program launched in Pennsylvania, Ohio
Barrier Therapeutics, Inc. - Dermatology firm reports loss of $0.66 per share
Baxter Healthcare S.A. - Positive opinion issued from French authorities for reimbursement of Advate
Baylor College of Medicine - Therapeutic targeting of CD18 integrins to exclude homing holds promise
Bio-One Corporation - Nutritional supplements firm reports second quarter revenue of $10.9M
Biovail Corporation - Regulatory approval granted for Tiazac XC in Canada
Bolder BioTechnology, Inc. - Protein engineering pharma company gets NIH grant for MS drug
Brigham and Women's Hospital - PPAR-gamma protects against acute gastric mucosal lesions
CEA Saclay - Immunoprecipitation of prion protein mediated by antibodies
CardioSpecialists Group Ltd - Lipid-lowering agents reduce cardiovascular event risk
Carrington Laboratories, Inc. - Pharmaceutical firm reports $7.99 in revenues
ChemDiv, Inc. - Yale University, collaborator receive phase I NIH grant for MC2R discovery
Childhood Obesity - Group supports childhood obesity reduction legislation
Children's Hospital of Philadelphia - High-dose steroids do not always cause bone loss in children
Children's National Medical Center - Virus-mediated p14(ARF) expression prompts apoptosis in osteosarcoma cells
Chinese University of Hong Kong - Environment and diet may explain different rates of asthma
Chiral Quest, Inc. - Pharmaceutical company introduces new name, VioQuest Pharmaceuticals, Inc.
Chromos Molecular Systems, Inc. - Cell-therapy company updates Q2, reports $1.4 million net loss
Cincinnati Children's Hospital - Study identifies rapidly rising disorder
Clarigen Inc. - Extracorporeal device efficiently removes endotoxin from whole blood
Cleveland Clinic Foundation - Nitric oxide synthase-2 pathway signals are impaired in cystic fibrosis
Cleveland Clinic Foundation - WBC count predicts long-term mortality after percutaneous coronary intervention
Columbia University - Gene expression in biopsy specimens has prognostic value
Cornell University - Surface peptidase expressed during wound healing is a tumor suppressor
Coronado Industries, Inc. - Glaucoma-device maker updates European activities
Curtin University of Technology - Domestic solvents, cleaning products may increase childhood asthma risk
Cytogen Corporation - Study shows improved 3-year biochemical control of recurrent prostate cancer
DOR BioPharma, Inc. - Biopharmaceutical company announces Q2 net loss of $1,473,376, updates progress
Dana-Farber Cancer Institute - Monoclonal antibody conjugate has potent antimyeloma activity
Dr. Harisingh Gour University - Cholera toxin bile-salt-stabilized vesicles for oral vaccines developed
DrugLogic, Inc. - Qscan Version 3 launched
Fukuoka University - Maximum tolerable dose of red pepper decreases fat intake
Genaera Corp. - Company reaches clinical milestone related to IL-9 antibody alliance
Genelabs Technologies, Inc. - Prestara clinical trial GL02-01 for women with lupus is complete
Genentech, Inc. - Rituximab-mediated depletion of healthy B cells elucidated
General Dynamics - Contract awarded for joint biological point detection systems
Genetronics Biomedical Corp. - Electroporation-focused company report Q2 net loss of $2.2 million
George Pompidou European Hospital - Peginterferon may cause sustained cryoglobulinemia-related vasculitis
GlycoGenesys, Inc. - Drug-development company discusses second-quarter losses
Hantavirus - CDC looking for cause of hantavirus as victim recovers
Harbor-UCLA Medical Center - Researchers identify mechanism underlying inflammatory joint disease
Harvard University - Cardiac effects of carbon monoxide, ambient particles studied in a rat MI model
Hemagen Diagnostics, Inc. - FDA issues 510(k) clearance for liquid stable reagents
Inion - Trinion Meniscus Screw receives FDA 510(k) clearance
Kyorin University, Tokyo - Probiotic treatment prevents/treats enterohemorrhagic E. coli O157:H7 infection
Medical Errors - Madisonville, Kentucky, hospital reviewing thousands of medical scans
Miravant Medical Technologies - Clinical results for SnET2 presented at ASRS meeting
POINT Biomedical Corporation - Ultrasound-imaging company raises $27.1 million in equity financing
Purdue University - Bright idea could improve blood safety, spell trouble for cancer and viruses
Rubicon Medical Corporation - Vascular medical device developer and Boston Scientific collaborate
U.S. Army - Lab's experience managing potential threats offers guidelines for others
U.S. Food & Drug Administration - FDA's regulatory role in the ICCVAM process outlined
U.S. Food & Drug Administration - Modifications of Charm II assay for chloramphenicol in honey described
Univ. of California, Irvine - Scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
University of Texas SW Medical Center - IRF-3 target genes constrain WNV infection and limit cell-to-cell virus spread
West Nile Virus - 83-year-old man is first Westchester, New York, resident with West Nile
West Nile Virus - Sixteen new West Nile cases, one death, reported in Louisiana
West Nile Virus - West Nile virus found in Oregon horses
Yale University - Novel method estimates time and size of bioterror attack for real-time use
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.